Nurse Practitioner, Adult Health · Bethpage, NY
NPI
1508147398
Since 2011
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
185 Central Ave
Bethpage, NY, 11714
Phone (516) 758-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
447 services
Medicare patients, 2024
194
Average age 71
Drug cost, 2024
$666K
276 prescriptions
Company payments, 2025
$27K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maly Tiev was code 91200 (standard x-ray), 137 times for 136 patients. In total Maly Tiev billed 447 services in 11 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 91200 Standard X-ray | Office | 137 | 136 | $24.78 | $3,394 |
| 99214 Office E&M - Established | Office | 107 | 75 | $99.64 | $11K |
| 36415 Venipuncture Blood Collection | Office | 106 | 78 | $8.57 | $908 |
| 99204 Office E&M - New | Office | 37 | 37 | $132.75 | $4,912 |
| G0010 Administration of hepatitis b vaccine | Office | 29 | 19 | $37.09 | $1,076 |
| 90739 Vaccine Product | Office | 23 | 17 | $162.54 | $3,738 |
By year: 2022 $20K for 200 services; 2023 $26K for 276 services; 2024 $25K for 447 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 106 | 78 | $8.57 | $908 |
Medicare prescription drug claims, 2024
In 2024, the drug Maly Tiev prescribed most often to Medicare patients was Rezdiffra (Resmetirom), with 67 prescriptions and refills. In total Maly Tiev wrote 276 Medicare prescriptions that cost $666K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rezdiffra Resmetirom | 67 | 83 | 19 | $317K |
| Vemlidy Tenofovir Alafenamide | 66 | 66 | Under 11 | $89K |
| Ursodiol Generic | 18 | 44 | Under 11 | $3,651 |
| Cholestyramine Cholestyramine (With Sugar) | 16 | 21 | Under 11 | $1,316 |
| Furosemide Generic | 13 | 19 | Under 11 | $57.26 |
| Xifaxan Rifaximin | 11 | 13 | Under 11 | $43K |
Brand drugs: 164 claims; generic drugs: 112 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maly Tiev $27K ($27K in general payments such as food, travel and fees) from 11 companies. The largest payer was Madrigal Pharmaceuticals with $14K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 31 | $14K |
| Mirum Pharmaceuticals, Inc. MIRM | 20 | $7,542 |
| Gilead Sciences, Inc. GILD | 14 | $4,297 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 10 | $1,540 |
| Novo Nordisk Inc NVO | 3 | $227 |
| Orphalan Inc | 2 | $54.44 |
| Intra-Sana Laboratories | 1 | $50 |
| Abbvie Inc. ABBV | 1 | $33.6 |
| Dexcom, Inc. DXCM | 1 | $23.58 |
| Lilly USA, LLC LLY | 1 | $16.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.